Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:58 PM
Ignite Modification Date:
2025-12-24 @ 10:58 PM
NCT ID:
NCT01305369
Eligibility Criteria:
Inclusion Criteria:
* Patients with chronic asthma, diagnosed based on the occurrence of episodic wheezing, chest tightness and/or dyspnoea and objectively confirmed according to standard criteria, such as methacholine airway hyper-responsiveness (PC20 FEV1 \< 16mg/ml) and positivity of skin test to common allergens (prick test)
* Positivity of bronchial challenge testing with mannitol
* Age range of 18-74 years old
* Duration of asthma \> 1 year
* Mild and stable asthma without chronic medication, except for the use of inhaled low dose of steroids or the use of inhaled beta2-agonist on demand
* Written informed consent
Exclusion Criteria:
* Pregnancy/lactation
* Active bleeding or high risk of bleeding contraindicating treatment with antiplatelet agents or anticoagulants
* Previous TIA or stroke
* Age ≥ 75 years old
* Other indication for anti-platelet therapy
* Systolic blood pressure \> 180 mmHg or diastolic blood pressure \> 110 mmHg
* Body weight \< 60 Kg
* Use of any FANS in the last 7 days
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
74 Years
Study:
NCT01305369
Study Brief:
Protocol Section:
NCT01305369